Children's Hospital of The King's Daughters, located in Norfolk, Virginia, United States, is the only freestanding children's hospital in Virginia. The hospital treats infants, children, teens, and young adults aged 0–21 and even some adults who require pediatric care.

There are 206 beds in Children's Hospital of The King's Daughters.

During the past decade, Children's Hospital of The King's Daughters conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 105 clinical trials were completed, i.e. on average, 80.8% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 47 clinical trials were completed. i.e. 82.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Hospital of The King's Daughters" #1 sponsor was "Children's Oncology Group" with 125 trials, followed by "National Cancer Institute (NCI)" with 59 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 8 trials sponsored and "Novartis Pharmaceuticals" with 8 trials sponsored. Other sponsors include 96 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Hospital of The King's Daughters" #1 collaborator was "National Cancer Institute (NCI)" with 128 trials as a collaborator, "Children's Oncology Group" with 9 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "Children's Hospital of The King's Daughters" with 6 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 5 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Children's Hospital of The King's Daughters" are "Recurrent Neuroblastoma" (21 trials), "Recurrent Osteosarcoma" (19 trials), "Neuroblastoma" (16 trials), "Sarcoma" (16 trials) and "HIV Infections" (15 trials). Many other conditions were trialed in "Children's Hospital of The King's Daughters" in a lesser frequency.

Most popular intervention types in "Children's Hospital of The King's Daughters" are "Drug" (242 trials), "Other" (105 trials), "Biological" (75 trials), "Procedure" (73 trials) and "Radiation" (56 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Cyclophosphamide" (37 trials), "Vincristine Sulfate" (33 trials), "Radiation Therapy" (28 trials) and "Etoposide" (27 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital of The King's Daughters" are 301 trials for "All" genders, 10 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 137 active trials in "Children's Hospital of The King's Daughters". 1 are not yet recruiting, 62 are recruiting, 69 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 159 completed trials in Children's Hospital of The King's Daughters, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital of The King's Daughters, 23 "Phase 1" clinical trials were conducted, 122 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".

Children's Hospital of The King's Daughters has several departments that took part in Clinical trials: "Virginia Pediatric Eye Center" - 10 trials, "Children's Hosp. of the King's Daughters, Infectious Disease" - 3 trials